EULAV Asset Management

Holdings History for VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)

Symbol: VRTX on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.27%	0%	$9,973,920	22,000	0		$453.36	Q4 2025
30 Sep 2025	0.2%	-0.01%	$8,616,080	22,000	-700	-3.1%	$391.64	Q3 2025
30 Jun 2025	0.24%	-0.06%	$10,106,040	22,700	-5,800	-20%	$445.20	Q2 2025
31 Mar 2025	0.34%	0%	$13,817,370	28,500	0		$484.82	Q1 2025
31 Dec 2024	0.28%	-0.03%	$11,476,950	28,500	-3,000	-9.5%	$402.70	Q4 2024
30 Sep 2024	0.36%	-0.05%	$14,650,020	31,500	-4,500	-12%	$465.08	Q3 2024
30 Jun 2024	0.46%	-0.02%	$16,873,920	36,000	-1,900	-5%	$468.72	Q2 2024
31 Mar 2024	0.44%	-0.01%	$15,842,579	37,900	-500	-1.3%	$418.01	Q1 2024
31 Dec 2023	0.48%	+0.06%	$15,624,576	38,400	+5,000	+15%	$406.89	Q4 2023
30 Sep 2023	0.42%	-0.03%	$11,614,516	33,400	-2,100	-5.9%	$347.74	Q3 2023
30 Jun 2023	0.47%	-0.03%	$12,492,805	35,500	-2,000	-5.3%	$351.91	Q2 2023
31 Mar 2023	0.47%	-0.06%	$11,815,125	37,500	-4,500	-11%	$315.07	Q1 2023
31 Dec 2022	0.52%	-0.07%	$12,128,760	42,000	-6,010	-13%	$288.78	Q4 2022
30 Sep 2022	0.62%	-0.08%	$13,901,000	48,010	-5,998	-11%	$289.54	Q3 2022
30 Jun 2022	0.63%	-0.07%	$15,219,000	54,008	-5,999	-10%	$281.79	Q2 2022
31 Mar 2022	0.47%	-0.16%	$15,660,000	60,007	-19,993	-25%	$260.97	Q1 2022
31 Dec 2021	0.44%	-0.16%	$17,568,000	80,000	-28,000	-26%	$219.60	Q4 2021
30 Sep 2021	0.52%	-0.16%	$19,590,000	108,000	-34,000	-24%	$181.39	Q3 2021
30 Jun 2021	0.76%	-0.04%	$28,631,000	142,000	-8,000	-5.3%	$201.63	Q2 2021
31 Mar 2021	0.86%	+0.41%	$32,234,000	150,000	+72,000	+92%	$214.89	Q1 2021
31 Dec 2020	0.48%	+0.19%	$18,435,000	78,000	+31,500	+68%	$236.35	Q4 2020
30 Sep 2020	0.37%	-0%	$12,654,000	46,500	-20	-0.04%	$272.13	Q3 2020
30 Jun 2020	0.44%	-0.04%	$13,505,000	46,520	-4,480	-8.8%	$290.31	Q2 2020
31 Mar 2020	0.49%	-0.07%	$12,135,000	51,000	-7,000	-12%	$237.94	Q1 2020
31 Dec 2019	0.44%	-0.08%	$12,699,000	58,000	-11,000	-16%	$218.95	Q4 2019
30 Sep 2019	0.43%	-0.02%	$11,690,000	69,000	-3,000	-4.2%	$169.42	Q3 2019
30 Jun 2019	0.49%	0%	$13,203,000	72,000	0		$183.38	Q2 2019
31 Mar 2019	0.55%	-0.05%	$13,396,000	72,000	-7,000	-8.9%	$186.06	Q1 2019
31 Dec 2018	0.65%	-0.13%	$13,091,000	79,000	-16,000	-17%	$165.71	Q4 2018
30 Sep 2018	0.78%	-0.1%	$18,310,000	95,000	-12,000	-11%	$192.74	Q3 2018
30 Jun 2018	0.84%	-0.08%	$18,186,000	107,000	-10,000	-8.5%	$169.96	Q2 2018
31 Mar 2018	0.91%	-0.12%	$19,069,000	117,000	-16,000	-12%	$162.98	Q1 2018
31 Dec 2017	0.94%	+0.06%	$19,931,000	133,000	+8,000	+6.4%	$149.86	Q4 2017
30 Sep 2017	0.9%	-0.03%	$19,005,000	125,000	-4,000	-3.1%	$152.04	Q3 2017
30 Jun 2017	0.81%	-0.05%	$16,624,000	129,000	-8,000	-5.8%	$128.87	Q2 2017
31 Mar 2017	0.76%	-0.03%	$14,981,000	137,000	-5,000	-3.5%	$109.35	Q1 2017
31 Dec 2016	0.56%	-0.02%	$10,461,000	142,000	-6,000	-4.1%	$73.67	Q4 2016
30 Sep 2016	0.68%	+0.06%	$12,907,000	148,000	+12,000	+8.8%	$87.21	Q3 2016
30 Jun 2016	0.64%	-0.05%	$11,699,000	136,000	-10,000	-6.8%	$86.02	Q2 2016
31 Mar 2016	0.65%	+0.11%	$11,606,000	146,000	+25,000	+21%	$79.49	Q1 2016
31 Dec 2015	0.83%	-0.01%	$15,225,000	121,000	-1,000	-0.82%	$125.83	Q4 2015
30 Sep 2015	0.72%	+0.57%	$12,705,000	122,000	+96,000	+369%	$104.14	Q3 2015
30 Jun 2015	0.17%	+0.17%	$3,210,000	26,000	+26,000	NEW	$123.46	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.